scholarly journals HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models

2014 ◽  
Vol 111 (51) ◽  
pp. 18297-18302 ◽  
Author(s):  
Luke Whitesell ◽  
Sandro Santagata ◽  
Marc L. Mendillo ◽  
Nancy U. Lin ◽  
David A. Proia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Hormonal Therapy ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Cancer Models ◽  
Evolution Of Resistance

Abstract 950: Src tyrosine kinase contributes to lapatinib resistance in human breast cancer models.

2013 ◽  
Author(s):  
Roberta Rosa ◽  
Lucia Nappi ◽  
Luigi Formisano ◽  
Claudia D'Amato ◽  
Valentina D'Amato ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Src Tyrosine Kinase ◽  
Cancer Models

Abstract 2260: Defining molecular mechanisms linking Endophilin A2 to metastasis in human breast cancer models

2015 ◽  
Author(s):  
Tomas Baldassarre ◽  
Kathleen Watt ◽  
Peter Truesdell ◽  
Mark Schneider ◽  
Sandip Sengupta ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Molecular Mechanisms ◽  
Human Breast ◽  
Cancer Models

Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants

2011 ◽  
Vol 26 (4) ◽  
pp. 530-537 ◽  
Author(s):  
Mohamed Chefrour ◽  
Gérard Milano ◽  
Patricia Formento ◽  
Sarah Giacometti ◽  
Amine Denden ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Positive Interaction ◽  
Cancer Models ◽  
Molecular Determinants

scholarly journals Initiating oncogenic event determines gene-expression patterns of human breast cancer models

2002 ◽  
Vol 99 (10) ◽  
pp. 6967-6972 ◽  
Author(s):  
K. V. Desai ◽  
N. Xiao ◽  
W. Wang ◽  
L. Gangi ◽  
J. Greene ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Human Breast Cancer ◽  
Expression Patterns ◽  
Gene Expression Patterns ◽  
Human Breast ◽  
Cancer Models

scholarly journals Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

2014 ◽  
Vol 105 (10) ◽  
pp. 1334-1342 ◽  
Author(s):  
Yasuhiro Funahashi ◽  
Kiyoshi Okamoto ◽  
Yusuke Adachi ◽  
Taro Semba ◽  
Mai Uesugi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tumor Microenvironment ◽  
Vascular Remodeling ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Eribulin Mesylate ◽  
Cancer Models

Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models

2017 ◽  
Vol 28 (7) ◽  
pp. 757-770 ◽  
Author(s):  
Patrick Aouad ◽  
Melody Saikali ◽  
Rana Abdel-Samad ◽  
Sabreen Fostok ◽  
Leeanna El-Houjeiri ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Three Dimensional ◽  
Two Dimensional ◽  
Human Breast ◽  
Antitumor Activities ◽  
Synthetic Retinoid ◽  
Cancer Models

Comparing Genetically Engineered Mouse Mammary Cancer Models with Human Breast Cancer by Expression Profiling1

2007 ◽  
Vol 28 (1) ◽  
pp. 39-51 ◽  
Author(s):  
Alexander N. Shoushtari ◽  
Aleksandra M. Michalowska ◽  
Jeffrey E. Green
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Mammary Cancer ◽  
Genetically Engineered ◽  
Human Breast ◽  
Cancer Models

scholarly journals GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo

2012 ◽  
Vol 18 (14) ◽  
pp. 3901-3911 ◽  
Author(s):  
Jeffrey J. Wallin ◽  
Jane Guan ◽  
Wei Wei Prior ◽  
Leslie B. Lee ◽  
Leanne Berry ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Human Breast Cancer ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Human Breast ◽  
Cancer Models
Sign in / Sign up

Export Citation Format

Share Document